XML 16 R17.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Income (Loss) per Common Share
9 Months Ended
Jun. 30, 2011
INCOME (LOSS) PER COMMON SHARE [Abstract]  
Earnings Per Share [Text Block]
INCOME (LOSS) PER COMMON SHARE
 
Income (loss) per common share is computed in accordance with ASC Topic 260, “Earnings per Share.” Presented below is a reconciliation of net income (loss) available to common shareholders and the differences between weighted average common shares outstanding, which are used in computing basic income (loss) per share, and weighted average common and potential shares outstanding, which are used in computing diluted income (loss) per share.  Diluted amounts are not included in the computation of diluted loss per share, as such amounts would be antidilutive.
 
 
 
Three months ended
 
Nine Months Ended
 
 
June 30,
 
June 30,
 
 
2011
 
2010
 
2011
 
2010
Net income (loss) available to common shareholders (in thousands)
 
$
2,768


 
$
360


 
2,574


 
(9,366
)
Weighted average common shares outstanding
 
27,184,248


 
27,436,616


 
27,963,097


 
27,339,511


Effect of dilutive securities:
 
 


 
 


 
 
 
 
Options
 
628,606


 
525,058


 
646,465


 


Weighted average common
and potential shares outstanding
 
27,812,854


 
27,961,674


 
28,609,562


 
27,339,511


Basic income (loss) per share
 
$
0.10


 
$
0.01


 
$
0.09


 
$
(0.34
)
Diluted income (loss) per share
 
$
0.10


 
$
0.01


 
$
0.09


 
$
(0.34
)
 
Certain options to purchase shares of the Company's common stock were not included in the weighted average common and potential shares outstanding in the computation of dilutive earnings per share, due to the antidilutive effects of a net loss:
 
 
 
Three months ended June 30,
 
Nine month periods ended June 30,
 
 
2011
 
2010
 
2011
 
2010
Common Stock Options
 
3,710,894


 
3,857,108


 
3,643,712


 
6,374,719


Range of exercise price
 
$3.69 - $18.71


 
$3.58 - $18.71


 
$3.50 - $18.71


 
$3.58 - $18.71


 
In the three and nine month period ended June 30, 2011, options to purchase approximately 3.7 million and 3.6 million shares of common stock, with exercise prices ranging from $3.69 to $18.71 for the three month period and $3.50 to $18.71 for the nine month period per share respectively, were not included in the computation of dilutive loss per share, due to their antidilutive effect.


In the three and nine month periods ended June 30, 2010, options to purchase approximately 3.9 million and 4.2 million shares of common stock, with exercise prices ranging from $3.58 to $18.71 per share respectively, were not included in the computation of dilutive loss per share, due to the antidilutive effect. In addition, for the nine month period ended June 30, 2010 approximately 2.2 million equivalent shares were not included, due to the loss generated in the period.